This brand name is authorized in New Zealand
The drug PRODOPA contains one active pharmaceutical ingredient (API):
|
1
Methyldopa sesquihydrate
UNII 56LH93261Y - METHYLDOPA
|
|
Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C02AB | Methyldopa | C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 2876 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
